Literature DB >> 11239500

Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.

C Meijera1, M J van Luyn, E F Nienhuis, N Blom, N H Mulder, E G de Vries.   

Abstract

Ultrastructural morphology (transmission electron microscopy) and localisation of cisplatin-induced platinum (Pt)-DNA adducts (immunoelectron microscopy) were analysed in the human small cell lung cancer cell line GLC(4) and its 40-fold in vitro acquired cisplatin-resistant subline GLC(4)-CDDP, which is characterised by, among other things, a decreased DNA platination. Immunolabelling of Pt-DNA adducts was performed with the polyclonal antibody GPt, known to detect the main Pt-containing intrastrand and interstrand DNA adducts. Morphological analysis of GLC(4) and GLC(4)-CDDP at the ultrastructural level showed cells with a high nucleus/cytoplasm ratio with the majority of nuclei containing one or more nucleoli. GLC(4)-CDDP showed, in contrast to GLC(4), an extensive Golgi apparatus and an increased number of mitochondria. DNA platination was detectable in both GLC(4) and GLC(4)-CDDP. Immunoelectron microscopy showed Pt-DNA adducts primarily in the nucleus, preferentially at loci with high-density chromatin (e.g. heterochromatin, pars granulosa around nucleoli, condensed DNA in proliferating and apoptotic cells), and in mitochondria. The level of detectable Pt-DNA adducts was cell cycle status-dependent. In both cell lines, Pt-DNA adduct levels increased from non-dividing interphase cells to dividing cells and were highest in cells undergoing apoptosis. Overall localisation of Pt-DNA adducts was comparable in GLC(4) and GLC(4)-CDDP cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239500     DOI: 10.1016/s0006-2952(00)00584-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

Review 1.  Binding of kinetically inert metal ions to RNA: the case of platinum(II).

Authors:  Erich G Chapman; Alethia A Hostetter; Maire F Osborn; Amanda L Miller; Victoria J DeRose
Journal:  Met Ions Life Sci       Date:  2011

2.  Differential effects of cisplatin on cybrid cells with varying mitochondrial DNA haplogroups.

Authors:  Sina Abedi; Gregory Yung; Shari R Atilano; Kunal Thaker; Steven Chang; Marilyn Chwa; Kevin Schneider; Nitin Udar; Daniela Bota; M Cristina Kenney
Journal:  PeerJ       Date:  2020-10-01       Impact factor: 2.984

3.  Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism.

Authors:  David M Mattson; Iman M Ahmad; Disha Dayal; Arlene D Parsons; Nukhet Aykin-Burns; Ling Li; Kevin P Orcutt; Douglas R Spitz; Kenneth J Dornfeld; Andrean L Simons
Journal:  Free Radic Biol Med       Date:  2008-10-18       Impact factor: 7.376

4.  NanoSIMS multi-element imaging reveals internalisation and nucleolar targeting for a highly-charged polynuclear platinum compound.

Authors:  Louise E Wedlock; Matt R Kilburn; Rong Liu; Jeremy A Shaw; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Commun (Camb)       Date:  2013-08-11       Impact factor: 6.222

Review 5.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

6.  Cisplatin-functionalized silica nanoparticles for cancer chemotherapy.

Authors:  Chandrababu Rejeeth; Tapas C Nag; Soundarapandian Kannan
Journal:  Cancer Nanotechnol       Date:  2013-07-20

7.  Electron microscopy in rat brain slices reveals rapid accumulation of Cisplatin on ribosomes and other cellular components only in glia.

Authors:  Lidia Zueva; Yomarie Rivera; Lilia Kucheryavykh; Serguei N Skatchkov; Misty J Eaton; Priscila Sanabria; Mikhail Inyushin
Journal:  Chemother Res Pract       Date:  2014-12-28

8.  Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney.

Authors:  A A Legin; S Theiner; A Schintlmeister; S Reipert; P Heffeter; M A Jakupec; J Mayr; H P Varbanov; C R Kowol; M Galanski; W Berger; M Wagner; B K Keppler
Journal:  Chem Sci       Date:  2016-02-03       Impact factor: 9.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.